Oral rotavirus vaccine trial for healthy infants
Part of Digestive system, Infections clinical trials.
This trial tests an oral vaccine given as drops to protect babies against rotavirus, a common cause of severe diarrhea. It is for healthy infants aged 6 to 12 weeks who have not had the rotavirus vaccine or infection before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby should be 6 to 12 weeks old (about 1.5 to 3 months) at the start.
- Your baby must not have received any rotavirus vaccine before.
- Your baby must not have had a rotavirus infection before.
- Your baby should have been born at full term (between 37 and 42 weeks of pregnancy).
- Your baby must be free of current diarrhea, vomiting, fever, or other serious illnesses in the past week.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study examines how the health of your digestive system affects how well your body responds to an oral rotavirus vaccine (a vaccine given by mouth to protect against rotavirus infection). You'll have two endoscopy procedures—a camera test to look inside your digestive tract—and provide samples to help researchers understand this connection.
This study tests whether a new vaccine safely protects infants aged 6 to 11 months against four types of meningococcal bacteria that can cause serious infections like meningitis and blood infections. It is designed for healthy babies who have not yet received any meningococcal vaccine.
This study tests an approved RSV vaccine given to pregnant women. The goal is to see if it safely protects their babies from severe RSV lung infections during the first months of life.
This study tests a new oral polio vaccine given to healthy infants at 16 weeks old. It aims to see if the vaccine is safe and works well to protect against polio.
This trial tests two doses of a dengue vaccine in healthy infants and toddlers aged 6 to 21 months. It aims to see if the vaccine is safe and helps protect against dengue fever.
This study tests a new combined vaccine that protects against several serious diseases in one shot. It aims to check if the vaccine is safe and works well in infants and toddlers.
Hear when a new Rotavirus Gastroenteritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.